Caspofungin Acetate: Brands, Price & Uses in Bangladesh

Caspofungin Acetate is an echinocandin-class antifungal administered intravenously under specialist supervision for serious systemic fungal infections. Indications are classified below by strength of evidence.

Established / FDA-approved uses

• Empirical therapy for presumed fungal infections in febrile, neutropenic patients.
• Candidemia and other Candida infections, including intra-abdominal abscesses, peritonitis, and pleural space infections caused by Candida species.
• Esophageal candidiasis.
• Invasive aspergillosis in patients who are refractory to or intolerant of other antifungal therapies (e.g., amphotericin B formulations or itraconazole).

Use requiring combination or salvage context

• In invasive aspergillosis, Caspofungin Acetate is used as salvage monotherapy after failure of first-line agents; it is not established as first-line or combination primary therapy for aspergillosis.

Caspofungin Acetate is not indicated for superficial or minor fungal infections and should be reserved for confirmed or strongly suspected serious systemic fungal disease, consistent with antifungal stewardship principles.

General

Caspofungin Acetate is given as a slow intravenous infusion over approximately 1 hour, once daily. It must never be administered as a bolus injection. Take Caspofungin Acetate exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice, consistent with antifungal stewardship.

Hepatic Impairment

In adults with moderate hepatic impairment (Child-Pugh score 7-9), give the standard 70 mg loading dose on Day 1, then reduce the maintenance dose to 35 mg once daily. Data in severe hepatic impairment are limited; use with caution. See Precautions for hepatotoxicity monitoring.

Concurrent Enzyme-Inducing Drugs

With sustained co-administration of rifampin or other strong inducers, increasing the maintenance dose of Caspofungin Acetate to 70 mg once daily should be considered (see Drug Interactions).

Renal Impairment

No dosage adjustment of Caspofungin Acetate is required for any degree of renal impairment.

Pediatric Dosing

See Use in Special Populations / Pediatric Uses for body-surface-area-based dosing.

Common

• Fever
• Infusion-site reactions (phlebitis/thrombophlebitis)
• Headache
• Nausea, vomiting, diarrhea, abdominal pain
• Elevated liver enzymes (transaminases, alkaline phosphatase)
• Rash, pruritus
• Hypokalemia
• Chills

Serious (less common)

• Anaphylaxis and other serious hypersensitivity reactions
• Histamine-mediated infusion reactions (facial swelling, bronchospasm, generalized rash, flushing) - see Precautions
• Significant hepatotoxicity, including hepatitis and, rarely, hepatic failure - see Precautions
• Rare severe cutaneous reactions (e.g., Stevens-Johnson syndrome)

Patients should seek prompt medical attention for signs of a serious reaction while receiving Caspofungin Acetate.